Literature DB >> 10982845

Isoforms of vascular endothelial growth factor act in a coordinate fashion To recruit and expand tumor vasculature.

J Grunstein1, J J Masbad, R Hickey, F Giordano, R S Johnson.   

Abstract

Vascular endothelial growth factor (VEGF) is an essential regulator of vascularization. It is expressed as several splice variants; the major forms contain 120 amino acids, 164 amino acids, and 188 amino acids. We utilized transformed cells nullizygous for VEGF to specifically express each of these isoforms in isolation, in order to determine the role of each in tumorigenic neo-vascularization. We found that only the intermediate isoform, VEGF164, could fully rescue tumor growth; VEGF120 partially rescued tumor growth, and VEGF188 failed completely to rescue tumor expansion. Surprisingly, the vascular density of VEGF188 isoform-expressing tumors is significantly greater than that of wild-type VEGF cells and the other isoform-specific tumors. The failure of the hypervascular VEGF188-expressing tumors to grow may be due to inadequate perfusion of the massive number of microvessels in these tumors; three-dimensional imaging of the tumorigenic vasculature indicated little or no recruitment of the peripheral vasculature. This demonstrates that the VEGF isoforms perform unique functions which together enable tumorigenic vascularization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982845      PMCID: PMC86282          DOI: 10.1128/MCB.20.19.7282-7291.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Vascular permeability factor, an endothelial cell mitogen related to PDGF.

Authors:  P J Keck; S D Hauser; G Krivi; K Sanzo; T Warren; J Feder; D T Connolly
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

Review 2.  [Therapeutic angiogenesis through intramuscular injection of the gene for vascular endothelial growth factor (VEGF)].

Authors:  J D Banga
Journal:  Ned Tijdschr Geneeskd       Date:  2000-01-15

3.  Xenografts of human solid tumors frequently express cellular-associated isoform of vascular endothelial growth factor (VEGF) 189.

Authors:  K Okamoto; Y Oshika; Y Fukushima; Y Ohnishi; T Tokunaga; Y Tomii; H Kijima; H Yamazaki; Y Ueyama; N Tamaoki; M Nakumura
Journal:  Oncol Rep       Date:  1999 Nov-Dec       Impact factor: 3.906

4.  RAG-1-deficient mice have no mature B and T lymphocytes.

Authors:  P Mombaerts; J Iacomini; R S Johnson; K Herrup; S Tonegawa; V E Papaioannou
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

5.  The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

Authors:  J E Park; G A Keller; N Ferrara
Journal:  Mol Biol Cell       Date:  1993-12       Impact factor: 4.138

6.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

Authors:  D R Senger; S J Galli; A M Dvorak; C A Perruzzi; V S Harvey; H F Dvorak
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

Review 7.  The vascular endothelial growth factor family of polypeptides.

Authors:  N Ferrara; K A Houck; L B Jakeman; J Winer; D W Leung
Journal:  J Cell Biochem       Date:  1991-11       Impact factor: 4.429

8.  Microvasculature architecture of small liver metastases in man. A correlation between microfil vascular preparations and histologic sections.

Authors:  G Lin; E Boijsen; I Hägerstrand; A Lunderquist
Journal:  Invest Radiol       Date:  1984 Jul-Aug       Impact factor: 6.016

9.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.

Authors:  D Shweiki; A Itin; D Soffer; E Keshet
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

10.  Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.

Authors:  K A Houck; D W Leung; A M Rowland; J Winer; N Ferrara
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

View more
  68 in total

1.  Dynamic modules and heterogeneity of function: a lesson from tyrosine kinase receptors in endothelial cells.

Authors:  F Bussolino; G Serini; S Mitola; G Bazzoni; E Dejana
Journal:  EMBO Rep       Date:  2001-09       Impact factor: 8.807

2.  Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis.

Authors:  Christiana Ruhrberg; Holger Gerhardt; Matthew Golding; Rose Watson; Sofia Ioannidou; Hajime Fujisawa; Christer Betsholtz; David T Shima
Journal:  Genes Dev       Date:  2002-10-15       Impact factor: 11.361

3.  Neutralization of vascular endothelial growth factor antiangiogenic isoforms or administration of proangiogenic isoforms stimulates vascular development in the rat testis.

Authors:  Michelle M Baltes-Breitwisch; Robin A Artac; Rebecca C Bott; Renee M McFee; Jill G Kerl; Debra T Clopton; Andrea S Cupp
Journal:  Reproduction       Date:  2010-05-10       Impact factor: 3.906

4.  Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma.

Authors:  Lin Zhang; Nuo Yang; Jose-Ramon Conejo Garcia; Alisha Mohamed; Fabian Benencia; Stephen C Rubin; David Allman; George Coukos
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

5.  CAPER-α alternative splicing regulates the expression of vascular endothelial growth factor₁₆₅ in Ewing sarcoma cells.

Authors:  Gangxiong Huang; Zhichao Zhou; Hua Wang; Eugenie S Kleinerman
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

6.  Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis.

Authors:  Shuei-Liong Lin; Fan-Chi Chang; Claudia Schrimpf; Yi-Ting Chen; Ching-Fang Wu; Vin-Cent Wu; Wen-Chih Chiang; Frank Kuhnert; Calvin J Kuo; Yung-Ming Chen; Kwan-Dun Wu; Tun-Jun Tsai; Jeremy S Duffield
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

7.  Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization.

Authors:  Selene Nunez-Cruz; Phyllis A Gimotty; Matthew W Guerra; Denise C Connolly; You-Qiang Wu; Robert A DeAngelis; John D Lambris; George Coukos; Nathalie Scholler
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

8.  Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization.

Authors:  Harukiyo Kawamura; Xiujuan Li; Katsutoshi Goishi; Laurens A van Meeteren; Lars Jakobsson; Stéphanie Cébe-Suarez; Akio Shimizu; Dan Edholm; Kurt Ballmer-Hofer; Lena Kjellén; Michael Klagsbrun; Lena Claesson-Welsh
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

9.  Neutralization of vascular endothelial growth factor antiangiogenic isoforms is more effective than treatment with proangiogenic isoforms in stimulating vascular development and follicle progression in the perinatal rat ovary.

Authors:  Robin A Artac; Renee M McFee; Robyn A Longfellow Smith; Michelle M Baltes-Breitwisch; Debra T Clopton; Andrea S Cupp
Journal:  Biol Reprod       Date:  2009-07-15       Impact factor: 4.285

10.  Inhibition of vascular endothelial growth factor receptor signal transduction blocks follicle progression but does not necessarily disrupt vascular development in perinatal rat ovaries.

Authors:  Renee M McFee; Robin A Artac; Ryann M McFee; Debra T Clopton; Robyn A Longfellow Smith; Timothy G Rozell; Andrea S Cupp
Journal:  Biol Reprod       Date:  2009-07-15       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.